Invizyne Technologies (NASDAQ:IZTC) Stock Price Up 0.6% - Here's What Happened

Key Points

• Invizyne Technologies Inc. (NASDAQ:IZTC) saw a stock price increase of 0.6%, trading at $9.76 with a significant drop in trading volume from the previous average.
• Institutional investors, including BNP Paribas Financial Markets and Citadel Advisors LLC, made new acquisitions in Invizyne Technologies during the fourth quarter, indicating growing interest in the company.
• The company's innovative approach involves cell-free enzyme-based biomanufacturing technology, which aims to transform natural resources into valuable biochemicals.

Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report)'s share price traded up 0.6% during mid-day trading on Tuesday . The company traded as high as $10.00 and last traded at $9.76. 2,698 shares were traded during mid-day trading, a decline of 93% from the average session volume of 37,647 shares. The stock had previously closed at $9.70.

Invizyne Technologies Price Performance

The stock has a 50 day moving average of $10.17 and a 200-day moving average of $12.51.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Citadel Advisors LLC purchased a new position in Invizyne Technologies during the 4th quarter valued at about $456,000. Geode Capital Management LLC bought a new stake in shares of Invizyne Technologies during the 4th quarter valued at about $277,000. Finally, BNP Paribas Financial Markets bought a new stake in shares of Invizyne Technologies during the 4th quarter valued at about $35,000.

About Invizyne Technologies

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.